Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Earnings Release 2015

Dec 18, 2014

65715_rns_2014-12-18_943eb6a8-58c0-4876-9084-343e73f989b4.pdf

Earnings Release

Open in viewer

Opens in your device viewer

==> picture [555 x 130] intentionally omitted <==

RESMED TO ANNOUNCE SECOND QUARTER 2015 RESULTS

San Diego, CA, December 18, 2014 -- RESMED INC. (NYSE: RMD) today announced that it will report its second quarter of fiscal year 2015 results on Thursday, January 22, 2015, after the New York Stock Exchange market close. A press release with ResMed’s results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.

The earnings call is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at http://investor.resmed.com. Please go to this section of the website and click on the icon for the “Q2 2015 earnings webcast.”

Please note that we are no longer using outside conference lines to access the earnings call.

International earnings webcast times will be:

9:30 p.m. London 8:30 a.m. Sydney, Australia (January 23, 2015)

A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from January 23, 2015 until February 5, 2015 at:

US: 630-652-3042 Outside US: +1 630-652-3042 Passcode: 38663898

About ResMed

ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information, please visit the company’s website at www.resmed.com.

Contacts

Investors: Agnes Lee Senior Director, Investor Relations (858) 836-5971 [email protected]

Media: Alison Graves Director, Global Corporate Communications (858) 836-6789 [email protected]